<?xml version="1.0" encoding="UTF-8"?>
<p id="p0035">More than 292 million people (3.9% of the worldâ€™s population) are estimated to be chronically infected with hepatitis B and an estimated further 58 million people with occult hepatitis B, resulting each year in more than 880,000 deaths worldwide from liver cirrhosis and liver cancer(1, 2). Hepatitis B disproportionately affects economically disadvantaged countries, with an estimated 248 million people living with hepatitis B residing in low- and middle-income countries (LMICs) in Asia, Africa, the Pacific and Latin America. These regions also bear the greatest hepatitis B-related mortality burden (
 <xref rid="bib1" ref-type="bibr">1</xref>, 
 <xref rid="bib2" ref-type="bibr">2</xref>, 
 <xref rid="bib3" ref-type="bibr">3</xref>).
</p>
